These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21455074)

  • 1. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial.
    Sauer M; Stahn A; Soltesz S; Noeldge-Schomburg G; Mencke T
    Eur J Anaesthesiol; 2011 Dec; 28(12):842-8. PubMed ID: 21455074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis.
    Fruergaard K; Viby-Mogensen J; Berg H; el-Mahdy AM
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1168-74. PubMed ID: 9834799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit.
    Murphy GS; Szokol JW; Marymont JH; Greenberg SB; Avram MJ; Vender JS; Nisman M
    Anesthesiology; 2008 Sep; 109(3):389-98. PubMed ID: 18719436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium chloride coadministered with neostigmine on neuromuscular blockade recovery: A double-blind randomised study.
    Ju JW; Kim HC; Yoon S; Hong DM; Park HP
    Eur J Anaesthesiol; 2017 Sep; 34(9):617-622. PubMed ID: 28763316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF; Kopman DJ; Ng J; Zank LM
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual neuromuscular block as a risk factor for critical respiratory events in the post anesthesia care unit.
    Norton M; Xará D; Parente D; Barbosa M; Abelha FJ
    Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):190-6. PubMed ID: 23453244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
    Schaller SJ; Fink H; Ulm K; Blobner M
    Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative residual neuromuscular blockade after reversal based on a qualitative peripheral nerve stimulator response: A randomised controlled trial.
    Lee YJ; Oh AY; Koo BW; Han JW; Park JH; Hong JP; Seo KS
    Eur J Anaesthesiol; 2020 Mar; 37(3):196-202. PubMed ID: 31977627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine administration of neostigmine after recovery of spontaneous breathing versus neuromuscular monitor-guided administration of neostigmine in pediatric patients: a parallel, randomized, controlled study.
    Yang L; Hu N; Chang H; Yang D; Zuo Y
    Trials; 2023 Jan; 24(1):19. PubMed ID: 36611181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal.
    Esteves S; Martins M; Barros F; Barros F; Canas M; Vitor P; Seabra M; Castro MM; Bastardo I
    Eur J Anaesthesiol; 2013 May; 30(5):243-9. PubMed ID: 23344123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.